Incidence of breast cancer in the United States: current and future trends.
about
Optimal management of hormone receptor positive metastatic breast cancer in 2016Exemestane for breast cancer prevention: a critical shift?Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States.Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.Use of multiple imputation to correct for bias in lung cancer incidence trends by histologic subtype.US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.Overview of breast cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010.Breast Cancer Downstaging Practices and Breast Health Messaging Preferences Among a Community Sample of Urban and Rural Ugandan Women.RAS pathway biomarkers for breast cancer prognosis.Chondroitin sulfate-E is a negative regulator of a pro-tumorigenic Wnt/beta-catenin-Collagen 1 axis in breast cancer cells.How many etiological subtypes of breast cancer: two, three, four, or more?Use of imputed population-based cancer registry data as a method of accounting for missing information: application to estrogen receptor status for breast cancer.Palbociclib (PD 0332991) : targeting the cell cycle machinery in breast cancer.Seven In Absentia Homolog 2 (SIAH2) downregulation is associated with tamoxifen resistance in MCF-7 breast cancer cells.Breast cancer in Wales: time trends and geographical distribution.A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer.Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.Increase in Distant Stage Breast Cancer Incidence Rates in US Women Aged 25-49 Years, 2000-2011: The Stage Migration HypothesisDietary intakes of total and specific lignans are associated with clinical breast tumor characteristicsDNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes.Changing concepts: Menopausal hormone therapy and breast cancer.Improvements in US Breast Cancer Survival and Proportion Explained by Tumor Size and Estrogen-Receptor StatusOpportunities for molecular epidemiological research on ductal carcinoma in-situ and breast carcinogenesis: interdisciplinary approaches.A logistic regression model for predicting axillary lymph node metastases in early breast carcinoma patients.Modification of the association between recreational physical activity and survival after breast cancer by promoter methylation in breast cancer-related genes.Prolactin Promotes Breast Cancer Cell Migration through Actin Cytoskeleton Remodeling.Are incidence rates of adult leukemia in the United States significantly associated with birth cohort?Trends in co-prescribing of antidepressants and tamoxifen among women with breast cancer, 2004-2010.Changing patterns in the clinical characteristics of korean breast cancer from 1996-2010 using an online nationwide breast cancer databasePatterns in target-directed breast cancer research.Oncologists' Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up.Declining second primary ovarian cancer after first primary breast cancer.Combining mTOR Inhibitors with Chemotherapy and Other Targeted Therapies in Advanced Breast Cancer: Rationale, Clinical Experience, and Future DirectionsUptake of exemestane chemoprevention in postmenopausal women at increased risk for breast cancer.DNA methylation modifies the association between obesity and survival after breast cancer diagnosis.Divergent estrogen receptor-positive and -negative breast cancer trends and etiologic heterogeneity in Denmark.Perinatal characteristics and breast cancer risk in daughters: a Scandinavian population-based study.Utility of Clinical Breast Examinations in Detecting Local-Regional Breast Events After Breast-Conservation in Women with a Personal History of High-Risk Breast Cancer.Evaluating breast cancer risk projections for Hispanic women.Managing breast cancer in the older patient.
P2860
Q26777683-5AA2D35E-B6F9-4F77-9A32-18F5006FCD62Q27028211-4234AE4D-EEE4-48B8-85D1-4586DDDF6245Q27300398-908EF675-21FC-4569-96E2-AA64DB5F74A2Q27300459-E35EE26D-B0CD-41F0-A3F9-2943FF1D3671Q30585673-0C45A806-0ADD-4A3E-9D6B-E2D0455F92C1Q30665329-223A296F-ADFE-4286-B079-079DC069BF56Q30870747-44475073-F52F-498B-8BBA-C907A230CA80Q33655655-347CE073-11ED-42AC-AAFF-7DFE4B0D8A19Q33757299-DECE1D79-10DE-43B0-B177-8AB1F8964503Q33999637-2E3C52DC-D3A8-4301-A61E-24DD1823D2A7Q34106175-41E74AD0-62EC-4478-9C22-F39ED4E0FEEAQ34355792-A6820968-D588-4198-9A67-D8FA61260692Q34394399-1BAA7AB8-AE07-4721-BCE0-96D3DA56A5E7Q34431899-CFA18878-C040-42B4-9FFA-D2A2351AB8CCQ34453037-08E7110C-C487-465F-8E88-CAA6DD9FB56AQ34968775-C9574B81-EAC9-481E-9805-B115AE881E28Q34994336-B60D469F-8B5C-4FE9-B213-CA1F1A374E0AQ35013062-62097498-6282-48FF-BEF0-D1684D6F8013Q35611018-7674DED0-9CFC-4CA6-BD05-4AEE90E1C374Q35835922-CD7A1DD2-645D-4CCF-A7A9-C665271097D9Q35866374-4AD888A1-EB03-4ABF-B5F6-F4843332CCD2Q36011148-7CC27E98-5E45-4299-8045-8498C8FE46C0Q36023456-80993F69-456A-4573-A3A2-96D984067D4DQ36239218-939789BE-29E8-4617-AFCD-A3972BFD3205Q36286909-59C650DC-23C1-4A4E-BFCE-C52E72CC720DQ36378657-18006016-A412-4FF5-8A7E-B3F6EF6EE2EAQ36457229-B2C43219-9C9B-4124-BB9D-87303425938AQ36487328-B3D7F972-CFF1-4941-8BB0-88FACA7EEA2DQ36525811-B182FD7B-AF37-4FAB-AE42-4F8CF7D8BFACQ36526547-E894340C-BD53-4E5B-ACAC-1EF0A0B51F0AQ36568129-9A4AB830-7250-4E0F-8902-26C0FAB44303Q36615095-4A9929E6-8A48-48E8-9CFC-28CBF98F2E39Q36629854-1AEEC86C-57E4-4AF9-A38A-2AB71E5A6A69Q36947842-6B3AB171-8F8C-4619-A3FE-9DCDB332CC19Q36961072-B435AAEA-1EE3-4EBB-93BB-0A5F22C09711Q37110296-1B82A158-1B86-497B-BA90-3143ABE09306Q37155763-58E5FE17-160B-475A-A2A8-793E20B15780Q37241359-4214B93D-79DB-4236-9813-3E7E5EC3B45FQ37307773-53124E60-8CFF-4CF6-98C5-B998E0BD9176Q37531318-A60397A0-5027-4962-ABBA-56746053270C
P2860
Incidence of breast cancer in the United States: current and future trends.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Incidence of breast cancer in the United States: current and future trends.
@ast
Incidence of breast cancer in the United States: current and future trends.
@en
type
label
Incidence of breast cancer in the United States: current and future trends.
@ast
Incidence of breast cancer in the United States: current and future trends.
@en
prefLabel
Incidence of breast cancer in the United States: current and future trends.
@ast
Incidence of breast cancer in the United States: current and future trends.
@en
P2860
P356
P1476
Incidence of breast cancer in the United States: current and future trends
@en
P2093
Hormuzd A Katki
William F Anderson
P2860
P304
P356
10.1093/JNCI/DJR257
P407
P577
2011-07-13T00:00:00Z